ABI3 Reduces Cancer Cell Growth and Induces Senescence
Author Information
Author(s): Flavia RM Latini, Jefferson P Hemerly, Beatriz CG Freitas, Gisele Oler, Gregory J Riggins, Janete M Cerutti
Primary Institution: Universidade Federal de São Paulo, SP, Brazil
Hypothesis
ABI3 expression might be reduced in thyroid carcinomas and possibly plays a functional role in the pathogenesis and/or progression of thyroid tumors as well as other cancers.
Conclusion
ABI3 expression is linked to cancer progression and may serve as a therapeutic target.
Supporting Evidence
- ABI3 expression is reduced in a high percentage of thyroid carcinomas.
- Ectopic expression of ABI3 led to lower tumor growth properties and increased cellular senescence.
- A positive correlation was observed between ABI3 and ABI3BP expression in malignant lesions.
Takeaway
The study found that a protein called ABI3 can help stop cancer cells from growing and make them age faster, which could be useful for treating cancer.
Methodology
The study involved analyzing ABI3 expression in thyroid tissue samples and conducting in vitro and in vivo experiments on cancer cell lines.
Limitations
The study primarily focused on thyroid and colon carcinoma cell lines, which may limit the generalizability of the findings to other cancer types.
Participant Demographics
Patients undergoing thyroid surgery for thyroid disease.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website